Literature DB >> 2298625

Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

W G Smit1, P A Helle, W L van Putten, A J Wijnmaalen, J J Seldenrath, B H van der Werf-Messing.   

Abstract

A retrospective analysis of the incidence of radiation proctitis was performed in 154 patients with carcinoma of the prostate treated with external radiotherapy assisted by CT-scan planning from 1983 to 1985. An attempt was made to assess a dose-response relationship for proctitis. Multivariate Cox regression analysis showed that previous bowel disease or surgery, anterior rectal dose, and average rectal dose contributed to a higher risk of proctitis. The anterior rectal dose was the most important indicator. No statistically significant correlation was found for the posterior rectal dose. The actuarial 2-year incidence of moderate or severe proctitis was 22% for anterior rectal doses less than 70 Gy and 20% for anterior rectal doses between 70 and 75 Gy, but increased to 60% when the dose was more than 75 Gy. A dose effect relation was evident, with a sharp dose-response gradient around 75 Gy at the anterior rectal wall.

Entities:  

Mesh:

Year:  1990        PMID: 2298625     DOI: 10.1016/0360-3016(90)90262-i

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

Review 2.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

3.  [Probability of seminal vesicle involvement in localized prostatic carcinoma. Significance in conformal radiotherapy].

Authors:  H J Feldmann; J Breul; F Zimmermann; S Wachter; T Wiegel
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

4.  Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Authors:  Xiaohua Ni; Yonggang Zhang; Judit Ribas; Wasim H Chowdhury; Mark Castanares; Zhewei Zhang; Marikki Laiho; Theodore L DeWeese; Shawn E Lupold
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

5.  Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.

Authors:  Katarzyna Behrendt; Elżbieta Nowicka; Marzena Gawkowska-Suwińska; Grzegorz Plewicki; Beata Smolska-Ciszewska; Monika Giglok; Rafał Suwiński; Aleksander Zajusz
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-15

Review 6.  The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.

Authors:  Tony Y Eng; Join Y Luh; Charles R Thomas
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 3.092

7.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

8.  High-dose-rate intensity modulated brachytherapy with external-beam radiotherapy improves local and biochemical control in patients with high-risk prostate cancer.

Authors:  P J Prada; H González; J Fernández; P Bilbao
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

Review 9.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

10.  The incidence of rectal bleeding following three-dimensional conformal radiotherapy of prostatic cancer.

Authors:  C Kurtman
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.